Free Trial
OTCMKTS:AZNCF

AstraZeneca (AZNCF) Stock Price, News & Analysis

AstraZeneca logo
$158.20 -2.45 (-1.53%)
As of 01:22 PM Eastern

About AstraZeneca Stock (OTCMKTS:AZNCF)

Key Stats

Today's Range
$158.20
$161.76
50-Day Range
$138.18
$162.98
52-Week Range
$120.64
$175.00
Volume
602 shs
Average Volume
2,818 shs
Market Capitalization
N/A
P/E Ratio
193.87
Dividend Yield
1.77%
Price Target
N/A
Consensus Rating
N/A

Company Overview

AstraZeneca Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
8th Percentile Overall Score

AZNCF MarketRank™: 

AstraZeneca scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for AstraZeneca.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of AstraZeneca is 193.87, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.69.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of AstraZeneca is 193.87, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 31.31.

  • Read more about AstraZeneca's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    AstraZeneca has a short interest ratio ("days to cover") of 125.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in AstraZeneca has recently decreased by 29.12%, indicating that investor sentiment is improving significantly.
  • Dividend Leadership

    AstraZeneca is a leading dividend payer. It pays a dividend yield of 3.89%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    AstraZeneca does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of AstraZeneca is 343.14%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about AstraZeneca's dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    AstraZeneca has a short interest ratio ("days to cover") of 125.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in AstraZeneca has recently decreased by 29.12%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    AstraZeneca has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for AstraZeneca this week, compared to 6 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, AstraZeneca insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    40.87% of the stock of AstraZeneca is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about AstraZeneca's insider trading history.
Receive AZNCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AZNCF Stock News Headlines

AstraZeneca bounces back from scandal in China
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
See More Headlines

AZNCF Stock Analysis - Frequently Asked Questions

AstraZeneca's stock was trading at $130.00 at the beginning of 2025. Since then, AZNCF stock has increased by 21.7% and is now trading at $158.1999.

AstraZeneca's top institutional investors include Boston Common Asset Management LLC.

Shares of AZNCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/28/2025
Next Earnings (Estimated)
11/06/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:AZNCF
CIK
901832
Fax
N/A
Employees
83,500
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
193.87
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:AZNCF) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners